I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 24% ± 5% | |
| oligodendrocyte | 4 studies | 23% ± 4% | |
| GABAergic neuron | 3 studies | 31% ± 8% | |
| glutamatergic neuron | 3 studies | 40% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 4 studies | 24% ± 5% | |
| oligodendrocyte | 4 studies | 23% ± 4% | |
| GABAergic neuron | 3 studies | 31% ± 8% | |
| glutamatergic neuron | 3 studies | 40% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 28% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1997.81 | 245 / 245 | 100% | 7.23 | 502 / 502 |
| brain | 100% | 1690.74 | 2642 / 2642 | 100% | 10.88 | 702 / 705 |
| adrenal gland | 99% | 1195.09 | 255 / 258 | 100% | 6.04 | 230 / 230 |
| thymus | 100% | 2259.65 | 653 / 653 | 98% | 6.50 | 595 / 605 |
| ovary | 100% | 3752.31 | 180 / 180 | 88% | 2.97 | 377 / 430 |
| breast | 99% | 1388.20 | 455 / 459 | 82% | 4.26 | 920 / 1118 |
| kidney | 100% | 1200.75 | 89 / 89 | 77% | 4.20 | 690 / 901 |
| pancreas | 84% | 458.17 | 275 / 328 | 80% | 2.36 | 143 / 178 |
| lung | 97% | 1032.69 | 561 / 578 | 58% | 1.82 | 670 / 1155 |
| bladder | 100% | 1782.71 | 21 / 21 | 53% | 1.87 | 266 / 504 |
| skin | 97% | 882.88 | 1746 / 1809 | 49% | 1.62 | 231 / 472 |
| uterus | 100% | 2747.98 | 170 / 170 | 41% | 1.88 | 189 / 459 |
| stomach | 94% | 932.58 | 336 / 359 | 33% | 0.89 | 95 / 286 |
| esophagus | 98% | 1518.84 | 1414 / 1445 | 27% | 0.80 | 50 / 183 |
| intestine | 96% | 1505.77 | 932 / 966 | 24% | 0.53 | 125 / 527 |
| blood vessel | 100% | 1652.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.49 | 1 / 1 |
| adipose | 99% | 1184.09 | 1192 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 98% | 709.42 | 235 / 241 | 0% | 0 | 0 / 0 |
| heart | 96% | 839.62 | 825 / 861 | 0% | 0 | 0 / 0 |
| muscle | 91% | 574.74 | 727 / 803 | 0% | 0 | 0 / 0 |
| liver | 52% | 229.44 | 117 / 226 | 33% | 0.89 | 133 / 406 |
| eye | 0% | 0 | 0 / 0 | 51% | 2.00 | 41 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 44% | 1.50 | 20 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.50 | 6 / 29 |
| peripheral blood | 0% | 1.16 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF471 |
| Protein name | Zinc finger protein 471 Zinc finger protein 471 (EZFIT-related protein 1) |
| Synonyms | KIAA1396 ERP1 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | ENST00000591537.5 [Q9BX82-2] Q9BX82 ENST00000308031.10 [Q9BX82-1] ENST00000591759.1 K7EPX1 |
